Andre Silvanovich

Bioinformatics and Sequence Analysis Lead, Monsanto Company

I joined Monsanto in 1999 after completing a Ph.D. in Cell and Developmental Biology at the University of Minnesota. I am a member of regulatory science organization where I apply my knowledge of bioinformatics, molecular biology and protein chemistry to address questions related to the safety of our biotechnology products.

From this Expert

Posted On: Monday, 7/29/2013 10:49 pm
A: The short answer is: while the initial transformation process can be described as a “shotgun” or random approach, researchers use numerous tools and techniques to eliminate all of the plants where the insertion occurred in an undesirable location or where the insertion could be disrupting or negatively impacting surrounding genes. Then researchers conduct rigorous safety tests on the remaining plants to make sure the insertion did not produce any new proteins—except for the protein that was... Continue Reading
No Studies were Found.